CPC Unites Innovative Clinical, Medical and Behavioral Science to Impact Health

set-04-250x250-04

Thirty years ago, CPC set out to develop impactful, innovative research to improve the lives of patients. Since its inaugural clinical trial—to look at how to best control blood pressure in people with diabetes—CPC has remained committed to its mission to unite academic leadership with operational expertise to optimize the quality of clinical research. Today the company offers a diverse array of biosciences industry clients fully-integrated clinical research and development services, including study planning and design, global project management, scientific and medical affairs leadership, data and site management, and regulatory affairs and quality management consulting.

 

And in the ever evolving and expanding biosciences landscape, along with clinical research and trials, CPC has embraced direct community engagement and community health as equally core to its mission. “I characterize CPC as a non-profit organization dedicated to really improving people’s lives through scientific research and community engagement,” said Dr. Marc P. Bonaca, MD, MPH and Executive Director of CPC who joined the company in 2018.  “Our research programs span multiple countries and populations while our community health programs seek to bring effective interventions into communities with health disparities to improve preventive care.”

 

Over the 30 years of CPC’s existence, the focus has been to bring together high-quality research and effective community interventions to both further the science but also to directly impact people’s lives. They run high-quality clinical research in over 30 countries to understand biology and the efficacy and safety of different interventions. At the same time, they engage local communities to apply evidence-based interventions to reduce risk. The interventions are delivered through local partnerships and supported by health navigators to help people reduce risk through interventions such as diet, exercise, and appropriate use of medications.

 

Today, CPC’s research programs range from Phase I through Phase IV studies and observational research in a variety of disease states. Funding comes from industry as well as through grants. CPC’s community health programs range from those focused on urban Latino populations to others centered on rural communities. The interventions are measured and demonstrated so they can help people in local communities improve cardiovascular risk factors such as lowering their blood pressure and cholesterol through diet, exercise, and appropriate use of medications.

 

“More recently our Community Health mission has expanded to include behavioral health because we recognize that social and behavioral determinants are absolutely critical to achieving better health,” according to Dr. Bonaca. “By adding the behavioral health component to risk prevention, we blend medical practices with more practical life skills to help patients attack and overcome their challenges.”

 

In addition to expanding into the Fitzsimons’ new Bioscience 3 development in 2020, CPC continues to embrace the opportunities of being part of the innovation community. “We believe there are incredible opportunities available by being in this rich and diverse research environment. For example, we are working on a collaborative cardio-oncology project to better understand the cardiovascular risk in patients with cancer exposed to certain therapies. This was only possible with the collaboration of talented investigators at the university, infrastructure such as Health Data COMPASS, and the clinical research skills and infrastructure at CPC,” said Dr. Bonaca.

 

“We feel that Fitzsimmons is a very special place, an epicenter for the innovators and innovations that will improve the lives of people globally,” said April Giles, vice president of business development for Fitzsimons. “Having opportunities to run into highly-specialized colleagues in the hallway, sit and have a coffee, share the care of a patient and conduct research are vital in bioscience. It’s our goal to create those opportunities—both facilitated by Fitzsimons and occurring organically—to discover synergies and launch ongoing opportunities for collaboration.”